Jens Rauch

3.0k total citations · 1 hit paper
34 papers, 2.2k citations indexed

About

Jens Rauch is a scholar working on Molecular Biology, Cell Biology and Oncology. According to data from OpenAlex, Jens Rauch has authored 34 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Cell Biology and 8 papers in Oncology. Recurrent topics in Jens Rauch's work include Melanoma and MAPK Pathways (14 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Computational Drug Discovery Methods (5 papers). Jens Rauch is often cited by papers focused on Melanoma and MAPK Pathways (14 papers), Protein Kinase Regulation and GTPase Signaling (8 papers) and Computational Drug Discovery Methods (5 papers). Jens Rauch collaborates with scholars based in Ireland, Germany and United States. Jens Rauch's co-authors include Walter Kölch, Shannon Lee, Marc R. Birtwistle, Natalia Volinsky, David Matallanas, Olivier Gires, Morteza Mahmoudi, Boris Ν. Kholodenko, Alex von Kriegsheim and Armin Zebisch and has published in prestigious journals such as Chemical Reviews, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Jens Rauch

34 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity

2020 576 citations Jens Rauch, Walter Kölch et al. International Journal of Molecular Sciences profile →

Peers

Countries citing papers authored by Jens Rauch

Since Specialization

Citations

This map shows the geographic impact of Jens Rauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Rauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Rauch more than expected).

Fields of papers citing papers by Jens Rauch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Rauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Rauch. The network helps show where Jens Rauch may publish in the future.

Co-authorship network of co-authors of Jens Rauch

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Rauch. A scholar is included among the top collaborators of Jens Rauch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Rauch. Jens Rauch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	A Combination of Conformation-Specific RAF Inhibitors Overcome Drug Resistance Brought about by RAF Overexpression	Biomolecules	Nora Rauch, Leonidas G. Alexopoulos et al.	5
2	Kinase Suppressor of RAS 1 (KSR1) Maintains the Transformed Phenotype of BRAFV600E Mutant Human Melanoma Cells	International Journal of Molecular Sciences	Aleksandar Krstić, Cristina Casalou et al.	5
3	Interactome dynamics of RAF1-BRAF kinase monomers and dimers	Scientific Data	Nora Rauch, Kieran Wynne et al.	5
4	Dissecting RAF Inhibitor Resistance by Structure-based Modeling Reveals Ways to Overcome Oncogenic RAS Signaling	Cell Systems	Oleksii S. Rukhlenko, Aleksandar Krstić et al.	50
5	Metabolic stress regulates ERK activity by controlling KSR‐RAF heterodimerization	EMBO Reports	Amandine Verlande, Michaela Krafčíková et al.	12
6	Evaluating Strategies to Normalise Biological Replicates of Western Blot Data	PLoS ONE	Andrea Degasperi, Marc R. Birtwistle et al.	165
7	Splicing factor hnRNP A2 activates the Ras-MAPK-ERK pathway by controlling A-Raf splicing in hepatocellular carcinoma development	RNA	Asaf Shilo, Ilan Stein et al.	86
8	Big Signals from Small Particles: Regulation of Cell Signaling Pathways by Nanoparticles	Chemical Reviews	Jens Rauch, Walter Kölch et al.	136
9	Emergence of bimodal cell population responses from the interplay between analog single-cell signaling and protein expression noise	BMC Systems Biology	Marc R. Birtwistle, Jens Rauch et al.	61
10	Cell Type-Specific Activation of AKT and ERK Signaling Pathways by Small Negatively-Charged Magnetic Nanoparticles	Scientific Reports	Jens Rauch, Walter Kölch et al.	48
11	c-Myc Regulates RNA Splicing of the A-Raf Kinase and Its Activation of the ERK Pathway	Cancer Research	Jens Rauch, Kim Moran‐Jones et al.	51
12	Raf Family Kinases: Old Dogs Have Learned New Tricks	Genes & Cancer	David Matallanas, Marc R. Birtwistle et al.	288
13	The secret life of kinases: functions beyond catalysis	Cell Communication and Signaling	Jens Rauch, Natalia Volinsky et al.	153
14	Heterogeneous Nuclear Ribonucleoprotein H Blocks MST2-Mediated Apoptosis in Cancer Cells by Regulating a-raf Transcription	Cancer Research	Jens Rauch, Eric O’Neill et al.	65
15	SEREX, Proteomex, AMIDA, and beyond: Serological screening technologies for target identification	PROTEOMICS - CLINICAL APPLICATIONS	Jens Rauch, Olivier Gires	13
16	CK8 correlates with malignancy in leukoplakia and carcinomas of the head and neck	Biochemical and Biophysical Research Communications	Olivier Gires, Brigitte Mack et al.	43
17	Allogenic antibody-mediated identification of head and neck cancer antigens	Biochemical and Biophysical Research Communications	Jens Rauch, Brigitte Mack et al.	62
18	Profile identification of disease-associated humoral antigens using AMIDA, a novel proteomics-based technology	Cellular and Molecular Life Sciences	Olivier Gires, C. Kieu et al.	57
19	Constitutive secretion of transgene-encoded IgG2b autoantibodies leads to symptoms of autoimmune disease	The Journal of Immunology	Marko Radic, Saleh Ibrahim et al.	19
20	A high frequency idiotypic marker of anti-DNA autoantibodies in MRL-Ipr/Ipr mice.	The Journal of Immunology	Jens Rauch, Emma Murphy et al.	122

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact